Cargando…
LY2405319, an analog of fibroblast growth factor 21 ameliorates α-smooth muscle actin production through inhibition of the succinate—G-protein couple receptor 91 (GPR91) pathway in mice
Fibroblast growth factor 21 (FGF21) is an important metabolic regulator expressed predominantly in the liver. In this study, we evaluated the role of LY2405319, an analogue of FGF21, in hepatic stellate cell (HSC) activation and in a methionine and choline-deficient (MCD)-diet induced mouse model of...
Autores principales: | Le, Cong Thuc, Nguyen, Giang, Park, So Young, Choi, Dae Hee, Cho, Eun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812602/ https://www.ncbi.nlm.nih.gov/pubmed/29444136 http://dx.doi.org/10.1371/journal.pone.0192146 |
Ejemplares similares
-
Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
por: Aguiar, Carla J, et al.
Publicado: (2014) -
The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016) -
Succinate induces aberrant mitochondrial fission in cardiomyocytes through GPR91 signaling
por: Lu, Yi-Tong, et al.
Publicado: (2018) -
Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
por: Kharitonenkov, Alexei, et al.
Publicado: (2013) -
Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91
por: Trauelsen, Mette, et al.
Publicado: (2017)